Last updated 2026-08-18
- Raised $5.2M Series A, Nov 2014
- Raised $4.1M Seed round, Jun 2012
- Raised Secondary, Oct 2022
Total raised
$9.3M
Stage
—
Founded
2000
Headcount
—
HQ
Jerusalem, Israel
Sector
Biotechnology
About
Izun Pharma is an emerging biopharmaceutical company with a product portfolio of powerful non-steroidal topical oral anti-inflammatory therapies with superior efficacy and safety to current periodontal treatments. The company aims to develop innovative topical drugs and products based on botanical sources addressing major, under-served markets. Izun Pharmaceuticals is also focused on oncology support, developing products that enable more effective cancer therapy and improve the quality of life for cancer patients. The company's core technology utilizes naturally derived pharmaceutical actives for the treatment of oral disease with inflammatory components.
Funding history · 3 rounds · $9.3M total
2022-10
Secondary
Undisclosed
2014-11
A Round
$5.2M
2012-06
Seed
$4.1M
Team · 5
William Levine
Founder · Founder & Chief Scientific Officer
Gabriel Nussbaum
Director of Scientific Affairs
Leslie Kraus
CFO
Shimon Lecht
Chief R&D Officer
Oscar Straus Schafer
Chairman
Sectors & technology
Primary sector
Biotechnology
Target customers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | izunpharma.com |
|---|
Identifiers & details
| Founded | 2000 |
|---|